Skip to main content
Equibles
CBIO logo

CBIO · Crescent Biopharma, Inc.

Track CBIO — free

Use CBIO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CBIO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$16.23 -1.09 (-6.29%) At close · Aug 20
Market Cap
$602.85M
Shares
37.14M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Model estimate

Expected Aug 14 short interest

as of Aug 14
3,344,318 -3.5% vs reported
The latest estimate appears in the chart below. Official release expected Aug 25. Methodology
Short Squeeze Score
66/100
Short interest 9.3% of shares — P88 Days to cover 8.9 — P87 Price vs VWAP -6.2% — P31 Short-volume trend -5.5% — P30 Short interest change -7.4% — P33 Worst FTD 0.53% of shares — P94

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 Scheduled
    FINRA publishes Aug 25
    		 — — — —
    2026-07-31 3,465,334 3,743,278 -277,944 8.92
    2026-07-15 3,743,278 3,673,343 +69,935 9.73
    2026-06-30 3,673,343 3,346,536 +326,807 7.03
    2026-06-15 3,346,536 3,257,490 +89,046 15.76
    2026-05-29 3,257,490 2,901,354 +356,136 11.27
    2026-05-15 2,901,354 2,395,086 +506,268 8.42
    2026-04-30 2,395,086 2,228,407 +166,679 8.87
    2026-04-15 2,228,407 2,238,781 -10,374 8.73
    2026-03-31 2,238,781 1,447,809 +790,972 9.07
    2026-03-13 1,447,809 1,445,957 +1,852 9.74
    2026-02-27 1,445,957 1,265,783 +180,174 8.80
    2026-02-13 1,265,783 1,113,469 +152,314 5.03
    2026-01-30 1,113,469 896,595 +216,874 5.43
    2026-01-15 896,595 794,628 +101,967 7.70
    2025-12-31 794,628 794,227 +401 8.62
    2025-12-15 794,227 562,655 +231,572 2.49
    2025-11-28 562,655 580,842 -18,187 11.61
    2025-11-14 580,842 577,578 +3,264 7.79
    2025-10-31 577,578 582,932 -5,354 5.60
    2025-10-15 582,932 502,379 +80,553 5.26
    2025-09-30 502,379 261,915 +240,464 3.33
    2025-09-15 261,915 128,532 +133,383 2.33
    2025-08-29 128,532 141,280 -12,748 1.24
    Showing 1–23 of 23 settlements
    Key facts CIK 1253689 CUSIP G2545C104 13F (30d) 77 filings 77 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)